UCSF Fresno — Fresno, California

Public research footprint of UCSF Fresno, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

COVID-19 · Covid19 · Diffuse Large B-Cell Lymphoma · Ann Arbor Stage II Follicular Lymphoma

Recently updated registry entries

NCT05100862 — A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants… (Active Not Recruiting)
NCT06191744 — Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… (Active Not Recruiting)
NCT06742996 — A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UCSF Fresno?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.